Glass House Brands Inc. ( GLASF) - Stock Earnings
Stock symbol GLASF is outdated, potentially delisted? Maybe it is available on other exchange?
GLASF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 7.8 million USD | 59.9 million USD |
| 2025Q3 | -9.2 million USD | 38.4 million USD |
| 2025Q4 | -11.8 million USD | 38.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GLASF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.2 million USD | 160.8 million USD |
| 2024 | 828060 USD | 200.9 million USD |
| 2025 | -18.2 million USD | 182.0 million USD |
| 2026 Est. | — | — |
GLASF
Price: $11.81
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.22 USD
P/E Ratio: -38.64
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 851.8 million